These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12947987)

  • 1. Local immunotherapy in allergy.
    Morris DL; Kroker GF; Sabnis VK; Morris MS
    Chem Immunol Allergy; 2003; 82():1-10. PubMed ID: 12947987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New applications for sublingual immunotherapy in allergy.
    Incorvaia C; Mauro M; Cappelletti T; Pravettoni C; Leo G; Riario-Sforza GG
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):113-7. PubMed ID: 19519587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-specific sublingual immunotherapy for respiratory allergy.
    Passalacqua G; Canonica GW
    BioDrugs; 2001; 15(8):509-19. PubMed ID: 11543692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.
    Incorvaia C; Ciprandi G; Nizi MC; Makri E; Ridolo E
    Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):245-257. PubMed ID: 32372588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland.
    Brüggenjürgen B; Reinhold T
    J Med Econ; 2018 Apr; 21(4):374-381. PubMed ID: 29271271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral.
    Frati F; Scurati S; Puccinelli P; Justicia JL; Adamec T; Sieber HJ; Ras L; David M; Marcucci F; Incorvaia C
    Expert Opin Biol Ther; 2009 Sep; 9(9):1207-15. PubMed ID: 19601728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different immunotherapy applications--different mechanisms? SLIT versus SCIT--differences in the mode of action.
    Allam JP; Bieber T; Novak N
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():237-40; discussion 240-5. PubMed ID: 20799467
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
    Pokladnikova J; Krcmova I; Vlcek J
    Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of respiratory allergy with allergy immunotherapy tablets.
    Bachert C
    Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of desensitization via the sublingual route in mite allergy.
    Guez S
    Chem Immunol Allergy; 2003; 82():62-76. PubMed ID: 12947993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual and oral immunotherapy.
    Canonica GW; Compalati E; Fumagalli F; Passalacqua G
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):685-704, vii. PubMed ID: 15474866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependence of efficacy but not of safety in sublingual immunotherapy.
    Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S
    Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy.
    Leader BA; Rotella M; Stillman L; DelGaudio JM; Patel ZM; Wise SK
    Int Forum Allergy Rhinol; 2016 May; 6(5):460-4. PubMed ID: 26718480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.